RxDoctor Payments Data

Raymond Dunn, MD

Plastic and Reconstructive Surgery · Worcester, MANPI 1225012347

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $29,488 of the $30,609 with a category attached, or 96.3%. Accutec Blades Inc accounts for 74.3% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2024 at $23,812 and has fallen 96.9% since, to $733 in 2025.

$30,609in general payments, 2019–2025

Across 28 payments — averaging $1093.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Accutec Blades Inc$23K
  • KCI USA, Inc.$5K
  • Avita Medical Americas, LLC$770
  • Vascular Technology, Inc.$500
  • Solventum Corporation$491
  • TELA Bio, Inc.$175
  • plus $761 from 11 others
$23,369in research payments, 2019–2025

Across 2 payments — averaging $11,684 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • KCI USA, Inc.$17K
  • Davol Inc.$6K

What the payments were for

  • Consulting fees$29,48896%
  • Food & beverage$1,1224%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$30,609 in reported general payments places this provider in the 85th percentile of 67 plastic and reconstructive surgery providers in Massachusetts.

See all plastic and reconstructive surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$69,354
Medicare patients
78
Services billed
209

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other plastic and reconstructive surgery in Worcester

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →